-
Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial
CONCLUSIONS: Both acarbose and vildagliptin treatments significantly reduced TMAO levels in newly diagnosed T2DM patients, with a more pronounced reduction observed in the acarbose group. Furthermore, the decline in TMAO levels correlated significantly with improvements in insulin resistance parameters. →
-
Adjuvant nonavalent HPV vaccination in women treated for vulvar HSIL, a randomized placebo-controlled trial; VulVaccin study protocol
BACKGROUND: Each year, 45,000 women worldwide develop vulvar cancer, often occurred from vulvar high-grade squamous intraepithelial lesions (vHSIL), a precancerous stage associated with high- risk human papillomavirus (HPV). Recurrent vHSIL, experienced by over 30% of patients despite treatment, conducting in significant physical and psychosocial challenges. With no established method to reduce recurrence, our study investigates… →
-
Results of a Randomized Controlled Trial Examining the Efficacy of Intranasal Oxytocin to Enhance Alcohol Behavioral Couple Therapy
Objective: This study examined the efficacy of intranasal oxytocin (40 IU), compared to matching placebo (saline), when combined with Alcohol Behavioral Couple Therapy (ABCT) for the treatment of alcohol use disorder (AUD). →
-
Meta Researchers Introduced J1: A Reinforcement Learning Framework That Trains Language Models to Judge With Reasoned Consistency and Minimal Data
Meta Researchers Introduced J1: A Reinforcement Learning Framework That Trains Language Models to Judge With Reasoned Consistency and Minimal Data Recent advancements in artificial intelligence have seen large language models (LLMs) evolving from traditional text generation roles to performing evaluation and judgment tasks. This shift has given rise to the concept of “LLM-as-a-Judge,” where models… →
-
Microsoft Phi-4: A New Era of AI Efficiency
In the ever-evolving world of artificial intelligence, breakthroughs don’t always mean bigger models; they often mean smarter, more efficient architectures. Microsoft’s Phi-4 series is a perfect illustration of this principle. By harnessing advanced training techniques and high-quality curated data, Microsoft has engineered a family of small language models that excel at complex reasoning tasks, yet… →
-
Sampling Without Data is Now Scalable: Meta AI Releases Adjoint Sampling for Reward-Driven Generative Modeling
Sampling Without Data is Now Scalable: Meta AI Releases Adjoint Sampling for Reward-Driven Generative Modeling Data Scarcity in Generative Modeling Generative models traditionally rely on large, high-quality datasets to produce samples that replicate the underlying data distribution. However, in fields like molecular modeling or physics-based inference, acquiring such data can be computationally infeasible or even… →
-
Step-by-Step Guide to Create an AI agent with Google ADK
Step-by-Step Guide to Create an AI Agent with Google ADK The Agent Development Kit (ADK) is an open-source Python framework that enables developers to build, manage, and deploy multi-agent systems. Its modular and flexible design makes it suitable for both simple and complex agent-based applications. Creating a Simple AI Agent In this tutorial, we will… →
-
The New Rules of Doing Business With China
Rob Dobi/theispot.com Geopolitical tensions between the West and China are deepening. As a result, Western governments, especially in the U.S. and Europe, are hardening their rules toward Chinese companies. Although many Western executives see these policies as moving in a common direction — toward an economic decoupling — this view is too limiting. Instead, by… →
-
Google AI Releases MedGemma: An Open Suite of Models Trained for Performance on Medical Text and Image Comprehension
Google AI Releases MedGemma: An Open Suite of Models for Medical Text and Image Comprehension At Google I/O 2025, Google introduced MedGemma, an open suite of models designed for multimodal medical text and image comprehension. Built on the Gemma 3 architecture, MedGemma aims to provide developers with a robust foundation for creating healthcare applications that… →
-
NVIDIA Releases Cosmos-Reason1: A Suite of AI Models Advancing Physical Common Sense and Embodied Reasoning in Real-World Environments
NVIDIA Releases Cosmos-Reason1: A Suite of AI Models Advancing Physical Common Sense and Embodied Reasoning in Real-World Environments AI has made significant strides in language processing, mathematics, and code generation. However, extending these capabilities to physical environments remains a challenge. Physical AI aims to bridge this gap by developing systems that perceive, understand, and act… →